BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype. World J Gastroenterol 2014; 20(10): 2482-2491 [PMID: 24627585 DOI: 10.3748/wjg.v20.i10.2482]
URL: https://www.wjgnet.com/1007-9327/full/v20/i10/2482.htm
(378) (385) (0) (0) (20011) (87)
Number Citing Articles
1
Kien Nguyen, Chu Manh Hung, Trinh Minh Ngoc, Dang Thi Thanh Le, Duc Hoa Nguyen, Duy Nguyen Van, Hieu Nguyen Van. Low-temperature prototype hydrogen sensors using Pd-decorated SnO2 nanowires for exhaled breath applications. Sensors and Actuators B: Chemical 2017; 253 doi: 10.1016/j.snb.2017.06.141
2
Humayra Dervin, Natalia Zarate‐Lopez, Rami Sweis, Alexia Mensah, Konstantinos Fragkos, Concetta Brugaletta, Amanda Raeburn, Anton Emmanuel. Low prevalence of positive hydrogen breath tests in patients with functional gastrointestinal conditions and hypermobile Ehlers–Danlos syndrome. Neurogastroenterology & Motility 2023; 35(9) doi: 10.1111/nmo.14570
3
Angeles Pérez Aisa, Mari Carmen García Gavilán, Julia Alcaide García, Isabel María Méndez Sánchez, Robin Rivera Irigoin, Francisco Fernández Cano, Teresa Pereda Salguero, Francisco Rivas Ruiz. Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status. Gastroenterología y Hepatología (English Edition) 2019; 42(1) doi: 10.1016/j.gastre.2019.01.007
4
Xiufang Cui, Haiyang Wang, Ziping Ye, Yi Li, Xinyun Qiu, Hongjie Zhang. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02015-w
5
G. Losurdo, A. Marra, E. Shahini, B. Girardi, F. Giorgio, A. Amoruso, A. Pisani, D. Piscitelli, M. Barone, M. Principi, A. Di Leo, E. Ierardi. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled‐data analysis. Neurogastroenterology & Motility 2017; 29(6) doi: 10.1111/nmo.13028
6
Siqi Lu, Yuzhu Chen, Huaizhu Guo, Zuojing Liu, Yanlin Du, Liping Duan. Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth. Digestive and Liver Disease 2024; 56(12) doi: 10.1016/j.dld.2024.07.011
7
Sanjeev Sachdeva, Amarender Singh Puri, Ajay Kumar, Ashok Dalal, Sahil Rahul Jain, Prisha Paliwal, Payila Satya Raghava Aneesh, Ravi Teja Reddy, Venkatesh Vaithiyam, Mayank Agarwal. Frequency and predictors of fructose malabsorption in patients with functional abdominal pain syndrome: A case-control study. World Journal of Gastrointestinal Pathophysiology 2026; 17(1): 113971 doi: 10.4291/wjgp.v17.i1.113971
8
Stephen D. H. Malnick, Sheral Ohayon Michael. The Intestinal Microbiome and the Metabolic Syndrome—How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD). Current Issues in Molecular Biology 2023; 45(9) doi: 10.3390/cimb45090455
9
Hani Essa, Shaheen Hamdy, Darren Green, Simon Lal, John McLaughlin, Sandra Hoffmann, Eugena Leitao, Peter Paine. Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post‐surgical patients. Neurogastroenterology & Motility 2021; 33(6) doi: 10.1111/nmo.14033
10
Roberta Poceviciute, Said R. Bogatyrev, Anna E. Romano, Amanda H. Dilmore, Octavio Mondragón-Palomino, Heli Takko, Ojas Pradhan, Rustem F. Ismagilov. Quantitative whole-tissue 3D imaging reveals bacteria in close association with mouse jejunum mucosa. npj Biofilms and Microbiomes 2023; 9(1) doi: 10.1038/s41522-023-00423-2
11
Michael Camilleri, David A. Katzka. Enhancing High Value Care in Gastroenterology Practice. Clinical Gastroenterology and Hepatology 2016; 14(10) doi: 10.1016/j.cgh.2016.05.022
12
Dong Woo Shin, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Senthamil R. Selvan. Effects of Alkaline‐Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double‐Blind, Placebo‐Controlled Pilot Study. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/9147914
13
Uday C. Ghoshal, Ujjala Ghoshal. Clinical and Basic Neurogastroenterology and Motility. 2020;  doi: 10.1016/B978-0-12-813037-7.00025-X
14
Uday C. Ghoshal, Ujjala Ghoshal. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders. Gastroenterology Clinics of North America 2017; 46(1) doi: 10.1016/j.gtc.2016.09.008
15
Uday C Ghoshal, Ujjala Ghoshal, Ayesha Shah, Gerald Holtmann. Evaluation of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology 2023; 17(5) doi: 10.1080/17474124.2023.2207008
16
Vlad Alexandru Ionescu, Gina Gheorghe, Teodor Florin Georgescu, Nicolae Bacalbasa, Florentina Gheorghe, Camelia Cristina Diaconu. The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome. Journal of Clinical Medicine 2024; 13(17) doi: 10.3390/jcm13175124
17
Kok Ann Gwee, Sutep Gonlachanvit, Uday C Ghoshal, Andrew S B Chua, Hiroto Miwa, Justin Wu, Young-Tae Bak, Oh Young Lee, Ching-Liang Lu, Hyojin Park, Minhu Chen, Ari F Syam, Philip Abraham, Jose Sollano, Chi-Sen Chang, Hidekazu Suzuki, Xiucai Fang, Shin Fukudo, Myung-Gyu Choi, Xiaohua Hou, Michio Hongo. Second Asian Consensus on Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2019; 25(3) doi: 10.5056/jnm19041
18
Emily K Stern, Darren M Brenner. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 2018; 9(2) doi: 10.1038/ctg.2018.2
19
Yoshiharu Uno. Pilot Study on Gas Patterns of Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth Following Ingestion of Lactulose. Open Journal of Gastroenterology 2015; 5(11) doi: 10.4236/ojgas.2015.511025
20
Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut and Liver 2017; 11(2) doi: 10.5009/gnl16126
21
LA Costa, TNF Gomes, CU Braga, L Lenz, SJ Miszputen, O Ambrogini. Irritable bowel syndrome and small intestinal bacterial overgrowth: Assessment with breath test. Archives of Clinical Gastroenterology 2020;  doi: 10.17352/2455-2283.000077
22
Angeles Pérez Aisa, Mari Carmen García Gavilán, Julia Alcaide García, Isabel María Méndez Sánchez, Robin Rivera Irigoin, Francisco Fernández Cano, Teresa Pereda Salguero, Francisco Rivas Ruiz. El sobrecrecimiento bacteriano de intestino delgado es una entidad frecuente tras gastrectomía, pero con escasa relevancia en el estado nutricional. Gastroenterología y Hepatología 2019; 42(1) doi: 10.1016/j.gastrohep.2018.07.001
23
Binrui Chen, Shuwen Zhu, Lijun Du, Huiqin He, John J. Kim, Ning Dai. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model. Scandinavian Journal of Gastroenterology 2017; 52(10) doi: 10.1080/00365521.2017.1342141
24
C. Bucci, A. Santonicola, P. Iovino. Probiotics, Prebiotics, and Synbiotics. 2016;  doi: 10.1016/B978-0-12-802189-7.00040-X
25
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status. Biology 2021; 10(5) doi: 10.3390/biology10050447
26
Stefan Hanf, Timea Bögözi, Robert Keiner, Torsten Frosch, Jürgen Popp. Fast and Highly Sensitive Fiber-Enhanced Raman Spectroscopic Monitoring of Molecular H2 and CH4 for Point-of-Care Diagnosis of Malabsorption Disorders in Exhaled Human Breath. Analytical Chemistry 2015; 87(2) doi: 10.1021/ac503450y
27
Arbind Kumar Choudhary, Anamitra Hait, Shyamala Ganesan, Sayan Howlader, Panneerselvam Periasamy. SIBO and intestinal methanogen overgrowth: breath test performance, treatment response, and relapse – a systematic review and meta-analysis. The Egyptian Journal of Internal Medicine 2026; 38(1) doi: 10.1186/s43162-026-00646-7
28
Alessandra Lo Presti, Francesca Zorzi, Federica Del Chierico, Annamaria Altomare, Silvia Cocca, Alessandra Avola, Fabiola De Biasio, Alessandra Russo, Eleonora Cella, Sofia Reddel, Emma Calabrese, Livia Biancone, Giovanni Monteleone, Michele Cicala, Silvia Angeletti, Massimo Ciccozzi, Lorenza Putignani, Michele Pier Luca Guarino. Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01655
29
Gourab Dutta Banik, Anulekha De, Suman Som, Subhra Jana, Sunil B Daschakraborty, Sujit Chaudhuri, Manik Pradhan. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS. Journal of Breath Research 2016; 10(2) doi: 10.1088/1752-7155/10/2/026010
30
Kang-Qi Wu, Wen-Jing Sun, Ning Li, Yu-Qin Chen, Yan-Ling Wei, Dong-Feng Chen. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scandinavian Journal of Gastroenterology 2019; 54(12) doi: 10.1080/00365521.2019.1694067
31
Charlotte K. Pitcher, Adam D. Farmer, Jordan J. Haworth, Sam Treadway, Anthony R. Hobson. Performance and Interpretation of Hydrogen and Methane Breath Testing Impact of North American Consensus Guidelines. Digestive Diseases and Sciences 2022; 67(12) doi: 10.1007/s10620-022-07487-8
32
Fanny Giron, Eamonn M M Quigley. Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective. Journal of Neurogastroenterology and Motility 2018; 24(3) doi: 10.5056/jnm18004
33
Bruno César da SILVA, Gabriela Piovezani RAMOS, Luisa Leite BARROS, Ana Flávia Passos RAMOS, Gerson DOMINGUES, Décio CHINZON, Maria do Carmo Friche PASSOS. DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY. Arquivos de Gastroenterologia 2025; 62 doi: 10.1590/s0004-2803.24612024-107
34
Kok‐Ann Gwee, Uday Chand Ghoshal, Minhu Chen. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. Journal of Gastroenterology and Hepatology 2018; 33(1) doi: 10.1111/jgh.13987
35
Wei Jia, Cynthia Rajani. Nutrition in the Prevention and Treatment of Disease. 2017;  doi: 10.1016/B978-0-12-802928-2.00038-2
36
Qinghua Sun, Qiong Jia, Lijin Song, Liping Duan. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome. Medicine 2019; 98(7) doi: 10.1097/MD.0000000000014513
37
David Willis, Donnie Cameron, Bahman Kasmai, Vassilios S. Vassiliou, Paul N. Malcolm, Gabriella Baio. A novel method for measuring bowel motility and velocity with dynamic magnetic resonance imaging in two and three dimensions. NMR in Biomedicine 2022; 35(5) doi: 10.1002/nbm.4663
38
Tarek Mazzawi. Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms 2022; 10(7) doi: 10.3390/microorganisms10071332
39
Brooks D. Cash, Brian E. Lacy, Tharaknath Rao, David L. Earnest. Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?. Expert Opinion on Pharmacotherapy 2016; 17(3) doi: 10.1517/14656566.2016.1118052
40
Hai-Ning Liu, Hao Wu, Yu-Zhuo Chen, Yan-Jie Chen, Xi-Zhong Shen, Tao-Tao Liu. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Digestive and Liver Disease 2017; 49(4) doi: 10.1016/j.dld.2017.01.142
41
Sanjeev Sachdeva, Ashok Dalal, Ajay Kumar, Aarushi Ahuja, Kartik Mehta, Ravi Teja Reddy, Venkatesh Vaithiyam, Chidanand Kumbar. Frequency and predictors of small intestinal bacterial overgrowth in acute pancreatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(2): 118784 doi: 10.4292/wjgpt.v17.i2.118784
42
Binrui Chen, John Jae-Woo Kim, Yawen Zhang, Lijun Du, Ning Dai. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. Journal of Gastroenterology 2018; 53(7) doi: 10.1007/s00535-018-1476-9
43
Sofia D. Shaikh, Natalie Sun, Andrew Canakis, William Y. Park, Horst Christian Weber. Irritable Bowel Syndrome and the Gut Microbiome: A Comprehensive Review. Journal of Clinical Medicine 2023; 12(7) doi: 10.3390/jcm12072558
44
Mohammad Jane Alam, A. S. M. Salimullah, Iqbal Hossain, Raj Dutta, Sadia Sultana Kamolika. Small intestinal bacterial overgrowth in irritable bowel syndrome: frequency and its association with socio-demographic and clinical factors. International Journal of Research in Medical Sciences 2025; 13(5) doi: 10.18203/2320-6012.ijrms20251287
45
Gourab D. Banik, Abhijit Maity, Suman Som, Chiranjit Ghosh, Sunil B. Daschakraborty, Sujit Chaudhuri, Shibendu Ghosh, Manik Pradhan. Diagnosis of small intestinal bacterial overgrowth in irritable bowel syndrome patients using high-precision stable13CO2/12CO2isotope ratios in exhaled breath. J. Anal. At. Spectrom. 2014; 29(10) doi: 10.1039/C4JA00186A
46
John Richard Thompson. Is irritable bowel syndrome an infectious disease?. World Journal of Gastroenterology 2016; 22(4): 1331-1334 doi: 10.3748/wjg.v22.i4.1331
47
Alexandra Celi, María Trelis, Lorena Ponce, Vicente Ortiz, Vicente Garrigues, José M. Soriano, Juan F. Merino-Torres. Food-Intolerance Genetic Testing: A Useful Tool for the Dietary Management of Chronic Gastrointestinal Disorders. Nutrients 2024; 16(16) doi: 10.3390/nu16162741
48
Emidio Scarpellini, Lucrezia Laterza, Gianluca Ianiro, Jan Tack, Ludovico Abenavoli, Antonio Gasbarrini. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 2016; 17(10) doi: 10.1080/14656566.2016.1182982
49
Sara Iqbal, Eamonn M. M. Quigley. Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician. Current Gastroenterology Reports 2016; 18(9) doi: 10.1007/s11894-016-0524-y
50
Wojciech Marlicz, Diana E Yung, Karolina Skonieczna-Żydecka, Igor Loniewski, Saskia van Hemert, Beata Loniewska, Anastasios Koulaouzidis. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Review of Gastroenterology & Hepatology 2017; 11(10) doi: 10.1080/17474124.2017.1343664
51
Jing Sun, Mengqiu Zhang, Wei Liu, Youqian Liu, Dongjian Zhang, Xinyu Fan, Jian Zhang, Tian Li, Min Lu. Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1160783
52
Hyo Jeong Lee, Jong Kyoung Choi, Han Seung Ryu, Chang Hwan Choi, Eun Hee Kang, Kyung Sik Park, Yang Won Min, Kyoung Sup Hong. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. Journal of Neurogastroenterology and Motility 2017; 23(1) doi: 10.5056/jnm16124
53
Emelia Kay, Sham Hawramee, Stephen Pollani, Ellen D. Mandel. Nonpharmacologic options for treating irritable bowel syndrome. JAAPA 2019; 32(3) doi: 10.1097/01.JAA.0000553384.82884.b8
54
Neha Garg, Srikanta Basu, Preeti Singh, Ruchika Kumar, Lokesh Sharma, Praveen Kumar. Prevalence of abnormal lactose breath hydrogen tests in children with functional abdominal pain. Indian Journal of Gastroenterology 2017; 36(3) doi: 10.1007/s12664-017-0750-8
55
Uday C. Ghoshal, Deepakshi Srivastava, Asha Misra, Ujjala Ghoshal. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth. European Journal of Gastroenterology & Hepatology 2016; 28(3) doi: 10.1097/MEG.0000000000000557
56
Uday C. Ghoshal, Sanjeev Sachdeva, Ujjala Ghoshal, Asha Misra, Amarender Singh Puri, Nitesh Pratap, Ayesha Shah, M. Masudur Rahman, Kok Ann Gwee, Victoria P Y Tan, Tahmeed Ahmed, Yeong Yeh Lee, B S Ramakrishna, Rupjyoti Talukdar, S V Rana, Saroj K Sinha, Minhu Chen, Nayoung Kim, Gerald Holtmann. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association. Indian Journal of Gastroenterology 2022; 41(5) doi: 10.1007/s12664-022-01292-x
57
Yousra Iftequar, Prakhar Bajpai, Rajvi Dav, Kaza Sri Harshitha, Chandan C, Rakshit Goel, Sneha Chimkar, Rishi Chowdhary. Targeted antibiotic and dietary approaches in managing small intestinal bacterial overgrowth across irritable bowel syndrome subtypes. Internal and Emergency Medicine 2026;  doi: 10.1007/s11739-026-04418-7
58
Sodaif Darvishmoghadam, Mehdi Ansari, Habibeh Ahmadipour, Mahnaz Azimipour, Maria Esmaeilzade, Mohammad Javad Zahedi, Mehdi Hayat Bakhsh Abbasi, Bijan Ahmadi, Amir Asadi, Fariba Sharififar. Assessment of the effect of sachet formulation of almond (Amygdalus dulcis L.) on diarrhea prominent irritable bowel syndrome (IBS-D) symptoms: A clinical trial. Complementary Therapies in Medicine 2019; 45 doi: 10.1016/j.ctim.2019.07.001
59
Weijie Yu, Shimeng Mou, Yingying Xue, Hangming Xiong, Yanjie Hu, Hao Wan, Ping Wang. Smart Electronic Nose for the Detection of Exhaled Breath to Diagnose Small Intestinal Bacterial Overgrowth. 2022 IEEE International Symposium on Olfaction and Electronic Nose (ISOEN) 2022;  doi: 10.1109/ISOEN54820.2022.9789641
60
Mohamadreza Yazdani, Amirhossein Aramesh, Rahmatollah Rafiei, Hamed Daghaghzadeh, Peyman Adibi. The comparison of treatments with and without azithromycin in irritable bowel syndrome with diarrhea-predominant in gastrointestinal Clinic of Al-Zahra Hospital, Isfahan, Iran. Advanced Biomedical Research 2016; 5(1) doi: 10.4103/2277-9175.192737
61
Uday C. Ghoshal, Kok-Ann Gwee. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nature Reviews Gastroenterology & Hepatology 2017; 14(7) doi: 10.1038/nrgastro.2017.37
62
Yasutada Akiba, Koji Maruta, Kazuyuki Narimatsu, Hyder Said, Izumi Kaji, Ayaka Kuri, Ken-ichi Iwamoto, Atsukazu Kuwahara, Jonathan D. Kaunitz. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 313(2) doi: 10.1152/ajpgi.00041.2017
63
David Avelar Rodriguez, Paul MacDaragh Ryan, Erick Manuel Toro Monjaraz, Jaime Alfonso Ramirez Mayans, Eamonn Martin Quigley. Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review. Frontiers in Pediatrics 2019; 7 doi: 10.3389/fped.2019.00363
64
Noor Mahmood Sultan, Abeer Abbas Ali, Hayder Jaleel Mardan. Isolation and Identification of the Types of Bacteria that Cause Irritable Bowel Syndrome. Medical Journal of Babylon 2025; 22(1) doi: 10.4103/MJBL.MJBL_185_22
65
Rajan Singh, Hannah Zogg, Lai Wei, Allison Bartlett, Uday C Ghoshal, Singh Rajender, Seungil Ro. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. Journal of Neurogastroenterology and Motility 2021; 27(1) doi: 10.5056/jnm20149
66
Bryan Zoll, Nitin K. Ahuja. Nutritional Therapies for Irritable Bowel Syndrome: a Focus on Prebiotics and Probiotics. Current Treatment Options in Gastroenterology 2020; 18(4) doi: 10.1007/s11938-020-00320-z
67
K. V. Ivashkin, V. R. Grechishnikova, M. S. Reshetova, V. T. Ivashkin. Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(1) doi: 10.22416/1382-4376-2021-31-1-54-63
68
Ying-Ying Lu, Jing-Jing Wang, Lun-Gen Lu, Wen-Hua Li, Zhong-Mei Pei, Zhen-Yu Cui, Meng-Jie Zhang, You Lu, Qiao-Li Jiang. Mucosal bacterial dysbiosis in patients with nodular lymphoid hyperplasia in the terminal ileum. World Journal of Gastroenterology 2022; 28(8): 811-824 doi: 10.3748/wjg.v28.i8.811
69
Shino Shimura, Norihisa Ishimura, Hironobu Mikami, Eiko Okimoto, Goichi Uno, Yuji Tamagawa, Masahito Aimi, Naoki Oshima, Shuichi Sato, Shunji Ishihara, Yoshikazu Kinoshita. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 2015; 22(1) doi: 10.5056/jnm15116
70
Hazel M. Ní Chonchubhair, Yasir Bashir, Mark Dobson, Barbara M. Ryan, Sinead N. Duggan, Kevin C. Conlon. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology 2018; 18(4) doi: 10.1016/j.pan.2018.02.010
71
Ayman Furqan, Muhammad Tauseef Sultan, Muhammad Usman Khalid, Muhammad Waqar, Muhammad Maaz, Laiba Tanvir, Rameen Naeem, Mutjardah Zarrish, Sabrin R. M. Ibrahim, Gamal A. Mohamed, Md. Sakhawot Hossain, Hagar M. Mohamed. Small Intestinal Bacterial Overgrowth: Microbiome Dysregulation, Gut–Brain Axis Disruption, and Systemic Consequences. Molecular Nutrition & Food Research 2026; 70(13) doi: 10.1002/mnfr.70541
72
Kamesh Gupta, Harparam Singh Ghuman, Shivani Vijay Handa. Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile. Clinical Medicine Insights: Gastroenterology 2017; 10 doi: 10.1177/1179552217728905
73
Na Deng, Siqin Xie, Qin Liu, Huiyi Peng, Leyao Fang, Junxi Shen, Xiaoyuan Lin. The intestinal microbiota modulates the visceral sensitivity involved in IBS induced by restraint combined with tail clustering. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1549617
74
Xiaojun Zhuang, Lishou Xiong, Li Li, Manying Li, Minhu Chen. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(1) doi: 10.1111/jgh.13471
75
Uday C. Ghoshal. Comprehensive Pharmacology. 2022;  doi: 10.1016/B978-0-12-820472-6.00107-9
76
A. V. Nalyotov, N. P. Guz. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(3) doi: 10.22416/1382-4376-2022-32-3-35-39
77
Pelagia-Irene Gouma, Fateh Mikaeili, Jusang Lee, Yasha Karimi, Milutin Stancevic. Sensing device for breath biomarker detection. 2019 IEEE International Symposium on Olfaction and Electronic Nose (ISOEN) 2019;  doi: 10.1109/ISOEN.2019.8823354
78
Yasutada Akiba, Takuya Inoue, Izumi Kaji, Masaaki Higashiyama, Kazuyuki Narimatsu, Ken‐ichi Iwamoto, Masahiko Watanabe, Paul H. Guth, Eli Engel, Atsukazu Kuwahara, Jonathan D Kaunitz. Short‐chain fatty acid sensing in rat duodenum. The Journal of Physiology 2015; 593(3) doi: 10.1113/jphysiol.2014.280792
79
Hua Chu, Mark Fox, Xia Zheng, Yanyong Deng, Yanqin Long, Zhihui Huang, Lijun Du, Fei Xu, Ning Dai. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/3230859
80
Chang Hwan Choi, Sae Kyung Chang. Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 2015; 22(1) doi: 10.5056/jnm15196
81
Shahnaz Mohammadi, Maryam Izadi-Mazi, Mahsa Akbarian-F. Anxiety and Quality of Life in patients with Irritable Bowel Syndrome. Journal of Medical Sciences 2015; 15(5) doi: 10.3923/jms.2015.235.240
82
David Avelar Rodriguez, Paul MacDaragh Ryan, Eamonn Martin Mary Quigley. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2022;  doi: 10.1007/978-3-030-80068-0_42
83
Ana M González‐Castro, Cristina Martínez, Eloísa Salvo‐Romero, Marina Fortea, Cristina Pardo‐Camacho, Teresa Pérez‐Berezo, Carmen Alonso‐Cotoner, Javier Santos, María Vicario. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2017; 32(1) doi: 10.1111/jgh.13417
84
Tarek Mazzawi, Gülen Arslan Lied, Dag André Sangnes, Magdy El-Salhy, Johannes R. Hov, Odd Helge Gilja, Jan Gunnar Hatlebakk, Trygve Hausken, John Green. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLOS ONE 2018; 13(11) doi: 10.1371/journal.pone.0194904
85
Andrés Acosta, Michael Camilleri, Andrea Shin, Sara Linker Nord, Jessica O'Neill, Amber V Gray, Alan J Lueke, Leslie J Donato, Duane D Burton, Lawrence A Szarka, Alan R Zinsmeister, Pamela L Golden, Anthony Fodor. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 2016; 7(5) doi: 10.1038/ctg.2016.32
86
Xiaojun Zhuang, Zhenyi Tian, Mei Luo, Lishou Xiong. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01336-6
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.